Acute liver dysfunction with delayed peak of serum aminotransferase levels as a presentation of ornithine transcarbamylase deficiency in females

Am J Med Genet A. 2021 Mar;185(3):909-915. doi: 10.1002/ajmg.a.62031. Epub 2020 Dec 24.

Abstract

We describe 10 females with ornithine transcarbamylase (OTC) deficiency and liver dysfunction, revealing a unique pattern of hepatocyte injury in which initial hyperammonemia and coagulopathy is followed by a delayed peak in aminotransferase levels. None of the patients required urgent liver transplantation, though five eventually underwent transplant for recurrent metabolic crises. We intend that this novel observation will initiate further investigations into the pathophysiology of liver dysfunction in OTC-deficient patients, and ultimately lead to the development of therapies and prevent the need for liver transplant.

Keywords: acute liver dysfunction; female manifestation of OTC deficiency; hepatic lyonization; hyperammonemia; ornithine transcarbamylase.

Publication types

  • Case Reports

MeSH terms

  • Age of Onset
  • Alanine Transaminase / blood*
  • Amino Acid Substitution
  • Aspartate Aminotransferases / blood
  • Biomarkers
  • Child, Preschool
  • Combined Modality Therapy
  • Developmental Disabilities / genetics
  • Disease Progression
  • Female
  • Hemorrhagic Disorders / etiology
  • Humans
  • Hyperammonemia / genetics
  • Infant
  • International Normalized Ratio
  • Liver Diseases / blood
  • Liver Diseases / etiology*
  • Liver Diseases / surgery
  • Liver Transplantation
  • Mutation, Missense
  • Ornithine Carbamoyltransferase Deficiency Disease / blood
  • Ornithine Carbamoyltransferase Deficiency Disease / complications*
  • Ornithine Carbamoyltransferase Deficiency Disease / diet therapy
  • Ornithine Carbamoyltransferase Deficiency Disease / surgery
  • Vomiting / genetics

Substances

  • Biomarkers
  • Aspartate Aminotransferases
  • Alanine Transaminase